What Do PRNP D178N and Codon 129 Mean for FFI Risk?

If a genetic test shows a PRNP D178N mutation, it means there is a genetic change in the DNA instructions that can cause an inherited prion disease ^[1]. However, finding this genetic risk alone does not mean a person currently has, or will definitely develop, the classic symptoms of Fatal Familial Insomnia (FFI). Whether this mutation is most strongly associated with FFI or a different clinical pattern, such as familial Creutzfeldt-Jakob Disease (fCJD), depends on a second piece of genetic information called codon 129 ^[2]. To predict the likely disease type, specialists must evaluate how the D178N mutation interacts with the codon 129 result on the exact same copy of the gene ^[2][3].

Note: This page focuses on interpreting genetic test results. For information on symptoms, disease management, and palliative care, please refer to the clinical sections of this guide.

Understanding PRNP D178N

The PRNP gene provides the instructions for making the prion protein in the body. A D178N result indicates a specific change in these DNA instructions that can promote abnormal prion-protein misfolding and alter disease behavior ^[4][5].

This mutation is inherited in an autosomal dominant pattern. This means that if a parent is a carrier, there is a 50% chance they will pass the variant to each of their biological children ^[6]. However, because the disease typically starts in mid-life and is highly variable, a parent might carry the mutation for decades without knowing it ^[7].

The Role of Codon 129

To understand the likely clinical pattern (phenotype), doctors look at another section of the PRNP gene called codon 129. Codon 129 is not a disease-causing mutation; it is a common normal genetic variation (a polymorphism) that modifies susceptibility and disease presentation. At this location, most people’s DNA codes for one of two amino acids: Methionine (M) or Valine (V).

Because you inherit one copy of the PRNP gene from each parent, your overall codon 129 result will be a combination of two letters: M/M, V/V, or M/V.

Cis vs. Trans (Phase) and Disease Risk

The most critical factor for predicting the disease pattern is determining which codon 129 variation (M or V) is physically located on the exact same gene copy as the D178N mutation. When two genetic features are on the same gene copy, they are in cis (this configuration is called the “phase”). If they are on opposite copies, they are in trans.

The relationship between D178N and codon 129 strongly predicts the clinical syndrome:

• D178N with 129M (in cis): This combination is classically associated with Fatal Familial Insomnia (FFI) ^[2][3].
• D178N with 129V (in cis): This combination is classically associated with familial Creutzfeldt-Jakob Disease (fCJD) ^[8].

If your overall codon 129 result is M/M or V/V, the phase is easy to determine (as both copies carry the same letter). However, if the overall result is M/V, a basic laboratory report might not specify whether the M or the V is on the mutated copy ^[2][3]. In this case, special laboratory testing is required to determine the phase.

Predicting the Disease is Not Perfect

While the combination of D178N and codon 129 in cis provides a strong guide, it does not guarantee one fixed presentation. FFI and fCJD are related clinical patterns that can overlap:

• Symptom overlap: Some individuals with the classic FFI genetic signature develop symptoms that look more like fCJD, such as cognitive or motor issues rather than severe sleep disturbances ^[9][10][11].
• Unpredictable timeline: The genetic result confirms an inherited risk, but it cannot predict exactly when symptoms will begin or how quickly they will progress. The age of onset can vary widely, even among members of the same family ^[12][7]. The codon 129 result on the normal gene copy can also influence the timeline; for instance, some studies suggest people who are M/V overall may have a longer disease duration than those who are M/M ^[12].
• Routine testing limitations: Specialized tests—such as MRI (brain scans), EEG (brain wave tests), and RT-QuIC (a specialized cerebrospinal fluid test that looks for prion-seeding activity)—are used to support a diagnosis. However, these tests can be unrevealing, especially early in the disease. A negative MRI, EEG, or RT-QuIC result does not rule out FFI ^[13][14].

Risk vs. Diagnosis and Family Testing

It is vital to distinguish between testing positive for a genetic risk (predictive testing for a healthy person) and receiving a clinical diagnosis of active FFI (diagnostic testing for someone with symptoms) ^[15][16]. A genetic test confirms the risk, but an active diagnosis requires a comprehensive clinical evaluation.

Because these results carry heavy emotional and practical implications for families, working with a certified genetic counselor and a neurologist specializing in prion diseases is essential ^[15][17]. Predictive testing for healthy adult relatives is completely voluntary and should always involve pre- and post-test counseling to discuss privacy, insurance, and family planning ^[17][18]. Furthermore, because FFI is an adult-onset condition, testing minors is strongly discouraged when there is no immediate childhood medical benefit ^[17].